|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.00 EUR | -.--% |
|
-.--% | - |
| 25-09-23 | PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 25-09-11 | PharmaSGP Holding SE Reaffirms Earnings Guidance for the Financial Year 2025 | CI |
| 1 year | 28 |  | 30 |
| 3 years | 17.7 | | 30 |
| 5 years | 17.7 | | 30 |
| 10 years | 14.4 | | 36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 2024-12-31 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 2020-03-03 |
| Director/Board Member | 45 | 2020-03-03 | |
Axel Rebien
BRD | Director/Board Member | 55 | 2020-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 447M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,063B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 611B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 444B | |
| -1.20% | -1.94% | +26.41% | +20.22% | 324B | |
| +4.94% | +3.39% | +39.92% | +28.93% | 285B | |
| +2.42% | +1.60% | +30.06% | +42.24% | 283B | |
| +2.47% | +5.18% | -24.80% | -39.60% | 219B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 195B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 156B | |
| Average | +2.11% | +4.52% | +30.79% | +55.80% | 397.85B | |
| Weighted average by Cap. | +1.85% | +5.23% | +41.55% | +80.68% |
Employees
98
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PSG Stock
- PSG Stock
Select your edition
All financial news and data tailored to specific country editions
